These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19250854)

  • 1. PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.
    Zimprich A; Schulte C; Reinthaler E; Haubenberger D; Balzar J; Lichtner P; El Tawil S; Edris S; Foki T; Pirker W; Katzenschlager R; Daniel G; Brücke T; Auff E; Gasser T
    Parkinsonism Relat Disord; 2009 Aug; 15(7):532-4. PubMed ID: 19250854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients.
    Guo Y; Jankovic J; Zhu S; Le W; Song Z; Xie W; Liao D; Yang H; Deng H
    Neurosci Lett; 2009 May; 454(3):209-11. PubMed ID: 19429085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GIGYF2 Asn56Ser mutation is rare in Chinese Parkinson's disease patients.
    Zhang Y; Zheng L; Zhang T; Wang Y; Xiao Q; Fei QZ; Cui PJ; Cao L; Chen SD
    Neurosci Lett; 2009 Oct; 463(3):172-5. PubMed ID: 19638301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.
    Lautier C; Goldwurm S; Dürr A; Giovannone B; Tsiaras WG; Pezzoli G; Brice A; Smith RJ
    Am J Hum Genet; 2008 Apr; 82(4):822-33. PubMed ID: 18358451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of variants of the GIGYF2 gene in Chinese patients with Parkinson’s disease.
    Wang L; Guo JF; Zhang WW; Xu Q; Zuo X; Shi CH; Luo LZ; Liu J; Hu L; Hu YC; Yan XX; Tang BS
    J Clin Neurosci; 2011 Dec; 18(12):1699-701. PubMed ID: 22115759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population.
    Samaranch L; Lorenzo E; Pastor MA; Riverol M; Luquin MR; Rodríguez-Oroz MC; Obeso JA; Pastor P
    Eur J Neurol; 2010 Feb; 17(2):321-5. PubMed ID: 19845746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up study of the GIGYF2 gene in French families with Parkinson's disease.
    Lesage S; Condroyer C; Lohman E; Troiano A; Tison F; Viallet F; Damier P; Tranchant C; Vidhaillet M; Ouvrard-Hernandez AM; Dürr A; Brice A;
    Neurobiol Aging; 2010 Jun; 31(6):1069-71; discussion 1072-4. PubMed ID: 20004041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population.
    Wang L; Guo JF; Zhang WW; Xu Q; Zuo X; Shi CH; Luo LZ; Liu J; Hu L; Hu YC; She L; Jiang H; Yan XX; Xia K; Pan Q; Tang BS
    Neurosci Lett; 2010 Apr; 473(2):131-5. PubMed ID: 20178831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients.
    Li L; Funayama M; Tomiyama H; Li Y; Yoshino H; Sasaki R; Kokubo Y; Kuzuhara S; Mizuno Y; Hattori N
    Neurosci Lett; 2010 Aug; 479(3):245-8. PubMed ID: 20641165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene.
    Guella I; Pistocchi A; Asselta R; Rimoldi V; Ghilardi A; Sironi F; Trotta L; Primignani P; Zini M; Zecchinelli A; Coviello D; Pezzoli G; Del Giacco L; Duga S; Goldwurm S
    Neurobiol Aging; 2011 Nov; 32(11):1994-2005. PubMed ID: 20060621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.
    Tan EK; Lin CH; Tai CH; Tan LC; Chen ML; Li R; Lim HQ; Pavanni R; Yuen Y; Prakash KM; Zhao Y; Wu RM
    Hum Genet; 2009 Sep; 126(3):425-30. PubMed ID: 19449032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.
    Di Fonzo A; Fabrizio E; Thomas A; Fincati E; Marconi R; Tinazzi M; Breedveld GJ; Simons EJ; Chien HF; Ferreira JJ; Horstink MW; Abbruzzese G; Borroni B; Cossu G; Dalla Libera A; Fabbrini G; Guidi M; De Mari M; Lopiano L; Martignoni E; Marini P; Onofrj M; Padovani A; Stocchi F; Toni V; Sampaio C; Barbosa ER; Meco G; ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2009 Nov; 15(9):703-5. PubMed ID: 19482505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GIGYF2 variants are not associated with Parkinson's disease in the mainland Chinese population.
    Cao L; Zhang T; Zheng L; Wang Y; Wang G; Zhang J; Fei QZ; Cui PJ; Wang XJ; Ma JF; Xiao Q; Chen SD
    Parkinsonism Relat Disord; 2010 May; 16(4):294-7. PubMed ID: 20044296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.
    Zhang Y; Sun QY; Yu RH; Guo JF; Tang BS; Yan XX
    Neurol Sci; 2015 Nov; 36(11):2073-9. PubMed ID: 26152800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population.
    Meeus B; Nuytemans K; Crosiers D; Engelborghs S; Pals P; Pickut B; Peeters K; Mattheijssens M; Corsmit E; Cras P; De Deyn PP; Theuns J; Van Broeckhoven C
    Neurobiol Aging; 2011 Feb; 32(2):308-12. PubMed ID: 19321232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease.
    Sutherland GT; Siebert GA; Newman JR; Silburn PA; Boyle RS; O'Sullivan JD; Mellick GD
    Mov Disord; 2009 Feb; 24(3):449-52. PubMed ID: 19117363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in GIGYF2 is not associated with Parkinson disease.
    Nichols WC; Kissell DK; Pankratz N; Pauciulo MW; Elsaesser VE; Clark KA; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
    Neurology; 2009 Jun; 72(22):1886-92. PubMed ID: 19279319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A
    Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease.
    Patra B; Parsian AJ; Racette BA; Zhao JH; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2009 Mar; 15(3):175-80. PubMed ID: 18752982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.